XTLBXTL Biopharmaceuticals
About XTL Biopharmaceuticals
XTL Biopharmaceuticals ADR (TLV:XTLB), (NASDAQ:XTLB) focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of autoimmune diseases. Their project pipeline mainly includes therapies aimed at conditions like systemic lupus erythematosus and multiple myeloma, showcasing a commitment to addressing hard-to-treat autoimmune disorders. The company's objectives are centered on advancing these projects through clinical trials towards regulatory approval, striving to meet unmet medical needs within these therapeutic areas. Their operations span from research and development to strategic partnerships aimed at enhancing their product portfolio and expanding their reach in the biopharmaceutical market.
What is XTLB known for?
Snapshot
Public US
Ownership
1993
Year founded
3
Employees
Herzliya, Israel
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
State of Israel
Produtos e/ou serviços de XTL Biopharmaceuticals
- Development of hCDR1 (edratide) for the treatment of systemic lupus erythematosus, a potential therapy aimed at reducing symptoms and disease progression.
- Research into therapies for multiple myeloma, focusing on small molecule drugs targeting specific pathways involved in the disease's progression.
- Advancement of potential treatments for hepatitis C, through the exploration of novel antiviral compounds that could inhibit the virus's ability to replicate.
- Investigation into autoimmune diseases, aiming to identify new therapeutic targets and develop innovative drugs to modulate the immune system.
- Conducting clinical trials for advanced drug candidates in inflammatory diseases, with a focus on achieving significant improvements in patient outcomes and quality of life.
- Collaboration with leading pharmaceutical companies and academic institutions to leverage cutting-edge research and development capabilities, enhancing the pipeline of therapies in various stages of development.
equipe executiva do XTL Biopharmaceuticals
- Mr. Noam BandCEO & Director
- Mr. Segal Niv CPAChief Financial Officer